Ostomy Readmission Reduction Program
ConditionOstomy - Ileostomy or Colostomy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCedars-Sinai Medical Center
About this trial
The purpose of this study is to reduce complications like peristomal skin issues, stoma-related problems, dehydration, and other preventable factors that can lead to re-hospitalization within the first 30 days after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Elective operations involving an ileostomy or a colostomy
Individuals 18 years old or older are included
Disqualifiers
Individuals under age 18
Pregnant patients
Emergency operations
Patients with existing pre operative ostomies
Trial population
The study population will be identified from our outpatient clinic during surgical consultations.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Preoperative Telehealth
Other interventionConduct a preoperative telehealth consultation with a Certified Wound, Ostomy, and Continence Nurse (WOCN) to provide patient education on post-surgical care expectations.
Measure Ostomy Output
Other interventionPatients will be sent home with a measuring container (graduated container) and will measure their ostomy output every 12 hours and record it in a pad that will be provided to them.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Readmission to hospital within 30 Days of Surgery
The proportion of participants who are readmitted to the hospital within 30 days following surgery. Readmissions will be evaluated for any reason, including complications, adverse events, or recovery issues that necessitate hospitalization after the initial surgical procedure.
Time frame
30 Days Post SurgerySecondary outcomes
1
Hospital Length of Stay
Total duration of hospitalization from the time of the index surgery until discharge.
Time frame
From index surgery to discharge (up to 30 days postoperatively)2
Incidence of Acute Kidney Injury (AKI)
Number of participants who develop AKI, defined as an increase in serum creatinine of ≥0.3 mg/dL from baseline, during index admission or upon 30-day readmission.
Time frame
From index surgery through 30 days postoperatively3
Incidence of Peristomal Skin Complications
Number of participants who develop peristomal skin problems (e.g., irritation, excoriation, or dermatitis) during the index admission or within 30 days postoperatively.
Time frame
From index surgery through 30 days postoperatively4
Incidence of Stoma-Related Leakage
Number of participants who experience unintended escape of stoma output (leakage) during index admission or within 30 days postoperatively.
Time frame
From index surgery through 30 days postoperativelySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: